Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study

J Affect Disord. 2002 Sep;71(1-3):195-8. doi: 10.1016/s0165-0327(01)00350-0.

Abstract

Background: No study has assessed systematically up to now the long-term outcome of lithium prophylaxis in bipolar patients with vs. without mood-incongruent psychotic features.

Methods: All bipolar patients with mood-incongruent psychotic features who started lithium prophylaxis at a lithium clinic during 14 years were followed up prospectively for 5 years, along with a control group of non-psychotic bipolars.

Results: Psychotic patients were significantly less likely than controls to be still on lithium after 5 years, and to present a reduction of at least 50% of time spent in hospital during the lithium treatment period compared with a pre-treatment period of the same duration. The time to 50% risk of readmission was significantly increased among both groups during lithium treatment. 39.6% of prospective episodes in psychotic patients did not include mood-incongruent psychotic features.

Limitations: This is a naturalistic study carried out at a lithium clinic. No control group of bipolar patients who did not receive lithium was available.

Conclusions: Lithium exerts a significant impact on the course of bipolar disorder with mood-incongruent psychotic features, although this impact is less pronounced than in classical manic-depressive illness.

MeSH terms

  • Adult
  • Antimanic Agents / administration & dosage
  • Antimanic Agents / therapeutic use*
  • Bipolar Disorder / prevention & control*
  • Disease Progression
  • Drug Administration Schedule
  • Female
  • Humans
  • Lithium Carbonate / administration & dosage
  • Lithium Carbonate / therapeutic use*
  • Male
  • Patient Readmission
  • Prognosis
  • Prospective Studies

Substances

  • Antimanic Agents
  • Lithium Carbonate